Sophrosyne Technologies

Based in India, Sophrosyne Technologies specializes in innovative health monitoring solutions that address the global challenges faced by healthcare systems, enhancing patient engagement and health management. Sophrosyne Technologies, founded in 2024 and headquartered in Bengaluru, India, focuses on developing advanced health monitoring technologies. The company has completed 1 deal, with its most recent funding round being a Seed round in November 2025, where it raised USD 2. 000 mn led by BlueHill Capital.

The founder's previous ventures are not detailed, and there are no known subsidiaries or parent companies. Sophrosyne Technologies specializes in health monitoring solutions aimed at addressing the pressing challenges faced by healthcare systems globally. The company focuses on developing advanced technology that enables continuous, connected, and intelligent health monitoring. Their flagship offerings include real-time health monitoring systems designed to empower users with actionable insights into their health status, facilitating early intervention in lifestyle diseases and chronic conditions.

Their products serve individual consumers and healthcare organizations, enhancing health outcomes across various geographical markets, including Asia, North America, and Europe. Sophrosyne Technologies generates revenue primarily through a B2B model, partnering with healthcare providers and organizations to deliver their monitoring solutions. The company offers subscription-based services, allowing clients continuous access to their health monitoring technology, including updates and support. The recurring fee agreements with healthcare institutions cover software access and necessary hardware installations.

Specific pricing details are not disclosed; however, the revenue structure aligns with robust healthcare solutions aimed at improving patient engagement and health management outcomes. In November 2025, Sophrosyne Technologies raised USD 2. 000 mn in Seed funding from BlueHill Capital. The company plans to utilize this funding to expand chip development, hire engineers, and support initial device integrations.

Additionally, they are looking to design and launch new health monitoring products aimed at various markets, with specific geographic expansion plans not disclosed.